STAT3 and hepatocellular carcinoma: M1-like macrophages can counteract HCC progression by modulating the tumor microenvironment, whereas M2-like macrophages can promote HCC cell proliferation and invasion by activating the TLR4/STAT3 signaling pathway [38,39].